Request for further standardization issues for future studies in paediatric haemophilia patients – Rebuttal to “Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis”

• References

• 1 den Uijl IEM, Fischer K. Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis. Thromb Haemost 2008; 99: 965.
• 2 Schobess R, Kurnik K, Friedrichs F. et al. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe hemophilia A – Results of a multicenter non-concurrent cohort study. Thromb Haemost 2008; 99: 71-76.
• 3 Berntorp E, Astermark J, Björkman S. et al. Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia 2003; 9: 1-4.
• 4 Ota S, Mclimont M, Carcao MD. et al. Definitions for haemophilia prophylaxis and its outcomes: The Canadian Consensus Study. Haemophilia 2007; 13: 12-20.
• 5 Pettersson H, Nilsson IM, Hedner U. et al. Radiologic evaluation of prophylaxis in severe haemophilia. Acta Paed Scand 1981; 70: 565-570.
• 6 Nuss R, Kilcoyne RF, Geraghty S. et al. MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage. Haemophilia 2000; 6: 162-169.
• 7 Fischer K, van der Bom JG, Mauser-Bunschoten EP. et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood 2002; 99: 2337-2341.
• 8 Kreuz W, Escuriola Ettingshausen C, Funk M. et al. Prevention of joint damage in hemophiliac children with early prophylaxis. Orthopäde 1999; 28: 341-346.
• 9 Manco-Johnson MJ, Abshire TC, Shapiro AD. et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-544.